Just-in-time cell-free expression of fresh target proteins

Functional display

Flexible array content

Proteins produced by human ribosomes and chaperone proteins, ensuring natural folding

Consistent protein levels across arrays

High reproducibility

Room temperature stable
and ready for use

Compatible with orthogonal immunoassays for verification

About Ordinatrix

Ordinatrix builds on over a decade of development and refinement of the Nucleic Acid Programmable Protein Arrays (NAPPA) technology. Ordinatrix provides a customizable solution for analysis of the proteome with the commercial introduction of the Nucleic Acid Programmable Protein Arrays (NAPPA) platform.  Our just-in-time protein production process allows us to provide customers with the screening of the complete human proteome comprising over 18,000 unique proteins, or selective target proteins of their choosing at the time of order.

Ordinatrix holds exclusive worldwide licenses to the NAPPA technology through licensing agreements with Arizona State University.

Our Mission

Our mission is to be the leader in translational proteomics through the creation of the most functional, flexible, and precise protein microarrays in the industry based on our attention to quality, intellectual property, and many years of experience with the Nucleic Acid Programmable Protein Arrays (NAPPA) technology, which will aid in the development of new drugs, diagnosis of disease and approaches to personalized medicine.

Management & Board Members

Advisory Board Members

Niro Ramachandran, PhD

Sally Caglioti

News